Enteric fever, encompassing typhoid and paratyphoid fever, remains a significant global health concern. Despite advancements in diagnostic techniques and treatments, it continues to pose challenges to healthcare professionals. This article aims to provide an updated approach to its diagnosis and management.
Diagnosis of enteric fever is based on clinical suspicion, epidemiological data, and laboratory confirmation. The gold standard remains blood culture, which, although only 40-60% sensitive, is 100% specific. Recent advances include the introduction of molecular methods such as PCR-based techniques, offering improved sensitivity and rapid results. Furthermore, serological tests, such as the Widal test, although less specific, provide a cost-effective alternative in resource-limited settings.
Treatment of enteric fever has been complicated by the emergence of multi-drug resistant strains. Current guidelines recommend empirical treatment with third-generation cephalosporins or fluoroquinolones pending culture results. In cases of known resistance or severe disease, azithromycin or a carbapenem may be considered. Vaccination, improved sanitation, and safe food and water practices remain crucial in prevention.
Despite these advancements, challenges persist in the diagnosis and treatment of enteric fever. These include the lack of a reliable, rapid diagnostic test, the emergence of drug resistance, and the varying efficacy of available vaccines. Future research should focus on the development of more sensitive and specific diagnostic tools, novel antimicrobial therapies, and more effective vaccines.
Enteric fever continues to be a significant health issue globally. While diagnostic and treatment modalities have evolved, challenges remain. As healthcare professionals, it is crucial to stay updated on the latest developments and adapt our approach accordingly. A comprehensive, patient-centered approach that includes prompt diagnosis, appropriate treatment, and preventive measures remains the cornerstone of managing enteric fever.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation